Investigating the effect of Duloxetine in improving complications caused by vincristine treatment in children with cancer
Phase 2
Recruiting
- Conditions
- Polyneuropathy.Drug-induced polyneuropathyG62.0
- Registration Number
- IRCT20230827059268N1
- Lead Sponsor
- Shahid Beheshti University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 56
Inclusion Criteria
Patients with an age range between 5 and 18 years
patients with Cancer who have been treated with vincristine
Patients who have complications and clinical symptoms of CIPN according to the clinical diagnosis of the relevant oncologist.
Exclusion Criteria
present other underlying polyneuropathies
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method